Akari Therapeutics Plc
AKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001541157
No open-market purchases or sales by Akari Therapeutics Plc insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.54M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Akari Therapeutics Plc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +1 vs. Q3 2022
- Shares held
- 8.92M
- −1.19M (−11.8%) vs. Q3 2022
- Total value
- $4.19M
- −$2.18M (−34.2%) vs. Q3 2022
- New holders
- 3
- 3 more added
- Sold out
- 2
- 3 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $1.54M |
| Q1 2026 | 6 | $308.2K |
| Q4 2025 | 21 | $1.29M |
| Q3 2025 | 16 | $1.18M |
| Q2 2025 | 15 | $644.3K |
| Q1 2025 | 11 | $377.3K |
| Q4 2024 | 14 | $393.8K |
| Q3 2024 | 10 | $535.9K |
| Q2 2024 | 10 | $488.1K |
| Q1 2024 | 8 | $326.3K |
| Q4 2023 | 9 | $891.6K |
| Q3 2023 | 8 | $1.19M |
| Q2 2023 | 16 | $1.71M |
| Q1 2023 | 12 | $1.84M |
| Q4 2022 | 15 | $4.19M |
| Q3 2022 | 14 | $6.37M |
| Q2 2022 | 14 | $1.68M |
| Q1 2022 | 11 | $1.89M |
| Q4 2021 | 11 | $2.16M |
| Q3 2021 | 14 | $1.99M |
| Q2 2021 | 12 | $2.27M |
| Q1 2021 | 15 | $3.90M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Akari Therapeutics Plc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Truvestments Capital LLC | 1,005 | $472 | 0.00% | −616−38.0% | Reduced |
| Bank of America Corp | 3,000 | $1.41K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 10,491 | $5.00K | 0.00% | +10,491 | New |
| Two Sigma Securities, LLC | 13,429 | $6.31K | 0.00% | +13,429 | New |
| Citadel Advisors LLC | 15,446 | $7.57K | 0.00% | +15,446 | New |
| Geode Capital Management, LLC | 30,264 | $14.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 55,450 | $26.0K | 0.00% | +15,400+38.5% | Added |
| Millennium Management LLC | 55,081 | $27.0K | 0.00% | +17,537+46.7% | Added |
| WSFS Capital Management, LLC | 100,000 | $47.0K | 0.01% | 00.0% | Unchanged |
| Hikari Power Ltd | 130,821 | $61.0K | 0.01% | 00.0% | Unchanged |
| LPL Financial LLC | 134,453 | $63.2K | 0.00% | +11,600+9.4% | Added |
| NEA Management Company, LLC | 452,167 | $212.5K | 0.01% | 00.0% | Unchanged |
| Omnia Family Wealth, LLC | 782,372 | $367.6K | 0.30% | 00.0% | Unchanged |
| Armistice Capital, LLC | 3,470,000 | $1.63M | 0.04% | −820,000−19.1% | Reduced |
| Sabby Management, LLC | 3,668,339 | $1.72M | 4.62% | −434,759−10.6% | Reduced |
| Haverford Trust Co | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −607−100.0% | Sold out |